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Abstract Human glycodelin, a lipocalin with a high amino acid
similarity to L-lactoglobulins, appears as various glycoforms with
different biological activities in endometrium (glycodelin-A) and
seminal plasma (glycodelin-S). We found that the structures of
these glycodelins and L-lactoglobulin are similar. Despite this
structural similarity, unlike L-lactoglobulin, glycodelin-A binds
neither retinoic acid nor retinol. It was impossible to detect any
endogenous retinoids or steroids in any of the two purified
glycodelins. Both their glycoforms share similar thermodynamic
parameters of reversible denaturation suggesting that native
folding of glycodelin-A and glycodelin-S is not influenced by the
differences in glycosylation or by ligand binding.
z 1999 Federation of European Biochemical Societies.
Key words: L-Lactoglobulin; Glycodelin; Glycosylation;
Lipocalin; Protein structure
1. Introduction
The lipocalin superfamily is a group of small extracellular
proteins [1,2], the members of which exhibit structural and
functional diversity but share three conserved sequence mo-
tifs. Their overall folding patterns are similar [1]. The gene
structures and localisations of their genes are also highly-con-
served [2,3]. Many, if not all, members of this family bind
small hydrophobic molecules. They also bind to speci¢c cell
surface receptors [1].
Glycodelin, previously known as placental protein 14 or
progesterone-associated endometrial protein, can be classi¢ed
in the lipocalin superfamily on the basis of its protein se-
quence [4]. Puri¢ed glycodelin-A (GdA) from amniotic £uid
displays contraceptive [5] and immunosuppressive properties
[6,7]. In the human male, seminal plasma contains an immu-
noreactive glycodelin called glycodelin-S (GdS). It cannot be
distinguished from GdA by currently available immunological
methods [9]. However, GdS is a di¡erentially glycosylated
form of glycodelin [8^10]. While their primary structures are
identical, unlike GdA, GdS has no contraceptive activity
[10,11]. This suggests that glycosylation determines the bio-
logical activities of these two glycodelins. In addition to the
di¡erences in glycosylation, alternatively-spliced glycodelin
transcripts have been reported [11^13]. Interestingly, transfec-
tion of glycodelin cDNA into MCF-7 breast cancer cells in-
duces epithelial di¡erentiation, decreases the proliferation rate
and induces apoptosis [14]. Retinoic acid treatment can induce
similar e¡ects [15].
Glycodelin exhibits a signi¢cant amino acid sequence sim-
ilarity with L-lactoglobulins, which strongly bind retinoic acid
and retinoids [4,16^18]. Hence, it was of interest to study
whether glycodelins would also bind these biologically active
substances and whether the di¡erences in their biological ac-
tivities are related to the structure or endogenously bound
ligand(s).
2. Materials and methods
2.1. Tertiary structure
The tertiary structure of glycodelin was deduced using the auto-
mated Swiss-Model service, which extrapolates a model for a target
sequence from the known three-dimensional (3D) structure of related
family members (template) [19^21]. We employed the Swiss-Model
with the ProMod protein modelling tool [21] for generating the pri-
mary model and the 3D pro¢le of the model [22] was used for quality
controls. The crystal structure of bovine L-lactoglobulin [23] (entry
1beb in the Brookhaven Protein Data Bank) was used as a template.
For searching proteins with a similar 3D structure, the proposed 3D
coordinates were compared to those from the Brookhaven Protein
Data Bank using the Dali (version 2.0) service [24]. Comparison be-
tween the L-lactoglobulin ligand binding site and the corresponding
region in glycodelin was performed using a Swiss-PDB Viewer.
2.2. Proteins
Glycodelin-A from amniotic £uid and the di¡erently-glycosylated
GdS from seminal plasma were puri¢ed as described before [9,25]. For
the detection of endogenously bound ligands, we omitted the addition
of Tris-bu¡er after elution from an anti-glycodelin Sepharose column.
For the elution, we used 0.1% tri£uoroacetic acid containing 1 mM
CaCl2. The subsequent steps of dialysis of GdA and GdS and the HiQ
puri¢cation of GdS were also omitted in the experiments in which
endogenously bound ligands were studied. L-lactoglobulin B was iso-
lated from the milk of a homozygous cow according to Maillart and
Ribadeau-Dumas [26]. Homogeneity of the protein preparation was
assessed by high performance gel permeation chromatography and
SDS gel electrophoresis. The obtained preparations of L-lactoglobulin
were over 98% pure.
2.3. Detection of endogenous retinoids or steroids
For the detection of endogenously bound ligands, we treated 32
nmol puri¢ed GdA (1 nmol equals to 28 Wg) or 17 nmol puri¢ed
GdS three times with 5 ml chloroform [27] to extract endogenous
retinoids, steroids or other ligands. We also treated 12 nmol puri¢ed
GdA and 17 nmol puri¢ed GdS with ethanol plus n-hexane [28]. The
chloroform and hexane phases were evaporated under nitrogen and
dissolved in chloroform or hexane, respectively. The extracts were
analysed by thin layer chromatography (TLC) using SIL G-25
UV254 plates (Macherey-Nagel, Du«ren, Germany) and benzene/ace-
tone/methanol (8/1/2, v/v/v) as a solvent. Hydrophobic ligands from
the hexane extraction were also analysed using hexane/diethyl ether/
acetic acid (80/20/2, v/v/v) as a solvent. All-trans-retinol, all-trans-ret-
inoic acid, progesterone and prostaglandin E2 (all from Sigma) were
used as molecular size and extraction controls.
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2.4. Exogenous binding
All-trans-retinol and all-trans-retinoic acid binding to GdA and L-
lactoglobulin were tested by £uorescence measurements according to
Dufour and Haertle¤ [29]. Fluorescence spectra were recorded with the
Aminco SLM 4800C spectro£uorometer at 20‡C in the ratio mode.
The concentrations of retinol and retinoic acid in ethanol stock sol-
utions were 686 and 705 WM, respectively. Aliquots (1^1.5 Wl) of the
ligand stock solutions were added to 1 ml protein solution containing
50 mM phosphate bu¡er, pH 7.0. Two sets of measurements were
carried out with 10.2 and 5.1 WM GdA solutions. The relative inten-
sity of £uorescence caused by the protein was measured at 330 nm
(excitation 282 nm) as a function of the ligand concentration. The
titration curves were corrected for the blank values provided by in-
jections of the corresponding stock solutions of the ligands into a
solution of N-acetyl-L-tryptophanamide, adjusted to the concentration
giving the same absorbance at 280 nm as did the glycodelin solution.
2.5. Circular dichroism spectroscopy
Circular dichroism spectra were measured at 25‡C with the Jobin
Yvon CD6 dichrograph. The spectra were an average of 10 accumu-
lated scans with subtraction of the baseline recorded for bu¡er solu-
tion (10 mM potassium phosphate, 1 mM EDTA at pH 6.6 and 20
mM glycine at pH 2.1). The protein concentration was 0.4^0.5 mg/ml.
Cylindrical cells of 0.02 cm path length were used.
2.6. Di¡erential scanning calorimetry
Calorimetric measurements were carried out using a high sensitivity
di¡erential scanning microcalorimeter (VP-DSC, MicroCal, North-
ampton, MA, USA) with a temperature range of 6^110‡C at a heating
rate of 60‡C/h and excess pressure of 32 psi. The protein solution was
dialysed overnight at 4‡C against 10 mM potassium phosphate con-
taining 1 mM EDTA at pH 6.6 or against 40 mM glycine at pH 2.1.
After dialysis, the protein concentration was determined spectropho-
tometrically assuming an extinction value of E1 mg=ml280nm = 1.0 in 1 cm cell
[30]. Calorimetric measurements were carried out using a 0.2 mg/ml
protein concentration. The molar heat capacity of GdA and GdS was
calculated assuming the molecular mass of the monomer (28 kDa).
Data processing was carried out with Origin 4.1 software (MicroCal).
3. Results
The sequence alignment of glycodelin with bovine L-lacto-
globulin is shown in Fig. 1. The modelled 3D structure of the
glycodelin monomer (Fig. 2) was found to be similar to the
crystal structure of bovine L-lactoglobulin [23]. These two
structures di¡ered only by 90.5 Aî root mean square deviation
(rmsd) in the K-carbon positions. Interestingly, all three po-
tential glycosylation sites of the glycodelins are localised on
the same side of the modelled molecule. The 3D pro¢le (not
shown) displays two regions with scores falling around 0.1
(average 0.44), which may re£ect unfavourably exposed non-
polar surfaces. At a physiological pH, the circular dichroism
spectrum of GdS is close to that of bovine L-lactoglobulin
(Fig. 3), suggesting similarity in their secondary structures.
In order to address whether GdA binds retinol or retinoic
acid, we used the £uorescence quenching method, which is
widely used for lipocalin ligand binding studies (Fig. 4). In
the case of GdA, one would expect that the e¡ect of bound
ligand on the quenching of tryptophan £uorescence should be
similar to that observed in L-lactoglobulin, since both trypto-
phans in L-lactoglobulin are conserved in the glycodelin se-
quence (Fig. 1). However, we found that with an increasing
retinol concentration, the £uorescence intensity of GdA varies
only slightly and almost linearly. The corresponding curve for
retinoic acid shows more deviation, probably due to turbidity
in the glycodelin/retinoic acid mixtures when the ligand con-
centration was high. The titration curves of glycodelin di¡ered
signi¢cantly from that of bovine L-lactoglobulin (Fig. 4). The
latter curve was typical for the binding isotherms with satu-
ration at the protein/ligand ratios 1. The results suggest that
there is no speci¢c binding of any tested retinoid ligand to
GdA under the conditions used. This means that, if any in-
teraction between glycodelin and retinol or retinoic acid ex-
ists, it must be very weak, with binding constants below
105^106 l/mol.
No endogenously bound ligands could be extracted from
GdA or GdS as detected by TLC suggesting that, if any hy-
drophobic ligands remain attached to the glycodelins during
puri¢cation, the amount must be very low. Compared to the
molar concentrations of glycodelins used in this study, the
methods we used could readily detect smaller or equimolar
quantities of retinoic acid, retinol, progesterone and prosta-
glandin E2 from aqueous solutions in the control experiments
(not shown).
We also measured by di¡erential scanning calorimetry the
Fig. 1. Sequence alignment of glycodelin (Gd) with bovine L-lactoglobulin (BLG) (amino acids 5^159 after the signal sequence from both pro-
teins) [4,23]. Identical residues are shaded (43% identity in the shown region).
Fig. 2. The Swiss-Model-deduced tertiary structure of the glycodelin
monomer. The S-S bridge is shown as a cylinder and the side chain
nitrogen atoms of asparagines of the potential glycosylation sites
are shown as balls. The model is generated by the automated Swiss-
Model service and visualised using a WebLab Viewer (Molecular
Simulations, San Diego, CA, USA).
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stability of the native conformations of GdA, GdS and bovine
L-lactoglobulin (Fig. 5). At pH 6.6, a single symmetrical peak
of the heat capacity was observed for both glycodelin glyco-
forms, typical of small globular proteins. Under these condi-
tions, the thermal denaturation of glycodelins was reversible:
the degree of reversibility for GdA and GdS was 81% and
93%, respectively, estimated from the percentage of reprodu-
cible peak area during re-heating of the protein sample. The
following values of thermodynamic denaturation parameters
were obtained for GdA and GdS, respectively: denaturation
temperature Td = 65.65‡C and 66.23‡C, denaturation enthalpy
per monomer vHcal = 296.0 kJ/mol and 312.2 kJ/mol, denatu-
ration heat capacity increment vCp = 7.22 kJ/mol/K and 10.10
kJ/mol/K. The di¡erence between GdA and GdS does not
exceed the usual level of accuracy in high sensitivity di¡er-
ential scanning calorimetry. We conclude that the two glyco-
delin glycoforms do not di¡er from each other by their ther-
modynamic stability at a physiological pH.
Fig. 5a shows that, at a physiological pH, the transition
temperature and unfolding pro¢le of glycodelin di¡ers sub-
stantially from that of bovine L-lactoglobulin. Compared to
L-lactoglobulin, the maximum of the unfolding peaks for gly-
codelins is observed at temperatures of about 15‡C lower and
the unfolding transition is much narrower. The di¡erence in
stability of the tertiary structures of GdS and L-lactoglobulin
is especially pronounced at acidic pH. At pH 2.1, L-lactoglo-
bulin shows a symmetrical denaturation peak at about 80‡C,
whereas GdS reveals no cooperative transitions on the ther-
mogram (Fig. 5b).
4. Discussion
The Swiss-Model-deduced tertiary structure of glycodelin
was found to be similar to that of L-lactoglobulin. This re-
mains in agreement with previous work of Sansom et al. [37]
who have classi¢ed PP14 protein (glycodelin) in what they
called the K2UG subfamily in which glycodelin is the closest
known ‘relative’ of BLG in the lipocalin phylogenetic tree
drawn by these authors.
Interestingly, in the Swiss-Model-deduced 3D structure, the
3D pro¢le of glycodelin shows two regions which may contain
unfavourably exposed non-polar surfaces. These regions are
apparently located on the same side of the glycodelin mole-
cule. Like some other lipocalins, glycodelin is a homodimeric
protein in its native state [1]. Therefore, it is possible that
regions with a low 3D score take part in the dimerisation
process. This would be expected because in L-lactoglobulin,
the corresponding regions form the dimer interface [23].
Fig. 3. Far-UV circular dichroism spectra of GdS and bovine L-lac-
toglobulin (BLG).
Fig. 4. Corrected £uorescence titration curves of (1^3) GdA and (4)
L-lactoglobulin with (1, 2, 4) retinol and (3) retinoic acid. Protein
concentration: (1) 10.2 WM, (2, 3) 5.1 WM and (4) 12.5 WM. 50 mM
phosphate bu¡er, pH 7.0.
Fig. 5. Heat capacity curves of GdA, GdS and bovine L-lactoglobu-
lin (BLG) (a) at pH 6.6, (b) pH 2.1. Heating rate = 60‡C/h; glycode-
lin concentration 0.20 mg/ml; L-lactoglobulin concentration 0.41
mg/ml.
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At a physiological pH, the circular dichroism spectrum of
GdS was found to be similar to that of L-lactoglobulin (Fig.
3). This observation is in agreement with a recent report by
Pala and co-workers [31] who found that GdA contains sig-
ni¢cant amounts of the L-sheet, which is almost identical to
that of L-lactoglobulin and other lipocalins [1,37].
The apparent similarity of the tertiary and secondary struc-
tures of glycodelin and L-lactoglobulin led us to investigate
how far their functional similarity might reach. The capacity
of glycodelin to bind retinol and retinoic acid was of great
interest because L-lactoglobulin (and also some other lipoca-
lins) can bind these so physiologically important retinoids.
First, retinol and retinoic acid were added to puri¢ed GdA,
L-lactoglobulin or bu¡er alone and the bound ligands were
separated by gel ¢ltration from the unbound, then extracted
and detected by TLC. However, the added retinoids precipi-
tate in aqueous solutions, hampering separation of unbound
retinoids from protein. Therefore, the £uorescence quenching
method was used demonstrating that, unlike bovine L-lacto-
globulin, GdA does not bind retinol or retinoic acid. The
puri¢ed GdA was not found to contain any detectable
amount of endogenously bound retinoids, steroids or other
hydrophobic ligands that would have been detected by the
TLC method used. Protein stability measurement by di¡er-
ential scanning calorimetry showed that, at a physiological
pH, the thermal stability of the two glycodelins di¡ers signi¢-
cantly from that of L-lactoglobulin (Fig. 5a). Because L-lacto-
globulin is irreversibly denatured when the homodimer is dis-
sociated, comparison of the unfolding of the two proteins by
quantitative thermodynamic parameters was impossible.
Although denaturation of the glycodelin homodimer is rever-
sible, glycodelins appear less stable than L-lactoglobulin
against thermal denaturation. Glycodelins reveal more coop-
erativity of their tertiary structure than L-lactoglobulin does.
This means that, despite considerable similarity in the overall
folding patterns of glycodelin and L-lactoglobulin, the stabil-
ising contacts in the folded conformations of these proteins
must be di¡erent. This is also supported by di¡erences in the
denaturation behaviour between GdS and L-lactoglobulin, ob-
served at a very low pH (Fig. 5b). Unlike GdS, L-lactoglobu-
lin retains cooperative properties of its tertiary structure down
to pH 1.0 and unfolds into a single cooperative folding unit
[32]. Compared to its behaviour at neutral pH (Fig. 3), the
GdS thermogram lacks any cooperative transitions at a low
pH and its secondary structure is also substantially perturbed.
Thus, the observed di¡erence in stability and cooperativity of
these two proteins [33] re£ects a deeper singularity in their
native folding patterns than those predicted from their struc-
tural similarity. Perhaps this is one of the reasons why GdA
does not bind retinol or retinoic acid, while L-lactoglobulin
does. Data of Beste et al. [39], who managed to engineer
considerable changes in the bilin binding protein binding spe-
ci¢city through randomised mutagenesis of the loop frag-
ments, indicate that binding speci¢cities of various lipocalins
are de¢ned by the composition of these fragments of their 3D
structure.
From two existing hypotheses on the localisation of the L-
lactoglobulin retinol binding site, preponderance of the cen-
tral cavity was proposed by Bronlow et al. [23] and in case of
palmitate binding by Wu et al. [38]. When the modelled gly-
codelin structure is compared with L-lactoglobulin, there is
only 0.25 Aî rmsd between K-carbons of the palmitate binding
site of L-lactoglobulin described by Wu et al. [38] as compared
to corresponding K-carbons of glycodelin. Of these, Val-41,
Leu-46, Ile-56, Lys-69, Ile-84 and Leu-103 were conserved.
Lys-60, Ile-71, Val-94, Phe-105, Met-107 of BLG were Arg-
60, Val-71, Leu-94, Leu-105, Leu-107 in glycodelin, respec-
tively.
An important di¡erence between the structures of L-lacto-
globulin and glycodelins is in their glycosylation. Unlike L-
lactoglobulin, both GdA and GdS are glycosylated [8,10,34].
Some of the glycans are very unusual for any secreted human
protein so far reported and some of these glycans were re-
ported to play a role in the cell adhesion processes [8,10].
Interestingly, in the Swiss-Model-deduced tertiary structure
presented here, these glycans are located in a way which
would allow them to form a clustered saccharide patch, i.e.
sugars from more than one glycosylation site could form a
cluster [35]. GdS is identical to GdA in its polypeptide se-
quence with the same glycosylation sites occupied by com-
pletely di¡erent glycans. Therefore, these two glycodelins pro-
vide an excellent model to study the e¡ect of di¡erential
glycosylation on the conformational stability of a given gly-
coprotein. As derived from high sensitivity di¡erential scan-
ning calorimetry data, the thermodynamic parameters of re-
versible unfolding of GdA and GdS are very similar. Thus,
the unusual glycosylation patterns of GdA and GdS do not
a¡ect their folding. Despite the similar folding conformations
of the two glycodelin glycoforms, their functions are very
di¡erent. Unlike GdS, GdA was shown to inhibit human
sperm-zona pellucida binding [5,10]. Because GdA and GdS
do not appear to contain any hydrophobic ligands and their
primary and tertiary polypeptide structures are similar, it is
likely that the contraceptive mechanism involves competitive
interaction between the GdA-type oligosaccharide moieties
and the surface carbohydrates of the oocyte. This type of
functional behaviour makes glycodelin di¡erent from most
other lipocalins, including L-lactoglobulin and retinol binding
protein. The latter reveals a 3D binding site, which is confor-
mation-dependent [36].
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